Skip to main content

Clinical trials: Antibody

UF Health research scientists make medicine better every day. They discover new ways to help people by running clinical trials. When you join a clinical trial, you can get advanced medical care. Sometimes years before it's available everywhere. You can also help make medicine better for everyone else. If you'd like to learn more about clinical trials, visit our clinical trials page. Or click one of the links below:

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS >/;20 HNSCC

This seamless phase 2/3 randomized controlled study will evaluate the efficacy and safety of the hexavalent OX40 agonist antibody INBRX-106 combined with the anti-PD-1 antibody pembrolizumab versus pembrolizumab (+ placebo in phase 3) as first-line…

Investigator
Dennie Jones
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
ADC MATCH Screening and Treatment Trial

This phase II ADC MATCH screening and multi-sub-study treatment trial is evaluating whether biomarker-directed treatment with one of three antibody-drug conjugates (ADCs) (sacituzumab govitecan, enfortumab vedotin, and trastuzumab deruxtecan) works…

Investigator
Thomas J George
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

News and patient stories: Antibody

More Antibody stories

Latest podcast episodes

Llama named Winter lends antibodies

A fluffy, long-necked cousin of the camel might be the key to protecting against SARS-like viruses. Yes, you heard that correctly. In a new study from researchers in Belgium, a team discovered a...

Listen to more Health in a Heartbeat episodes